Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence

Frontiers in Immunology(2025)10.3389/fimmu.2025.1596499Source: DataRank Database

CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence is a research paper published in Frontiers in Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 7.36)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Elton VanNoy,Stefanyda Maslova,Abigail Haffey ORCID,Khatereh Khorsandi ORCID,Natasha Sheybani ORCID

Live enrichment

PubMed:40612954 PMC:PMC12222291 OpenAlex:https://openalex.org/W4411427641

NIH HHS

Grant: DP5 OD031846

NCI NIH HHS

Grant: R00 CA256262

NCI NIH HHS

Grant: R21 CA292273

NCI NIH HHS

Grant: K99 CA256262

National Institutes of Health

Grant: 5R00CA256262-05

Improving CAR T cell therapy for brain tumors using immune competent models

National Institutes of Health

Grant: 5R03CA230573-02

Investigation of EDD's extraordinary tumorigenic activities

FWCI

7.36

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1596499/pdf

publisherhttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1596499/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1596499/full

journalhttps://doi.org/10.3389/fimmu.2025.1596499

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40612954

Fields of Study

CAR-T cell therapy researchAdvancements in Semiconductor Devices and Circuit DesignVirus-based gene therapy research03 medical and health sciences0302 clinical medicineHumansImmunotherapy, AdoptiveBrain NeoplasmsReceptors, Chimeric AntigenTumor MicroenvironmentAnimalsT-LymphocytesCell Movement

MeSH Terms

Receptors, Chimeric AntigenAnimalsBrain NeoplasmsCell MovementHumansT-LymphocytesImmunotherapy, AdoptiveTumor Microenvironment

Keywords

Chimeric antigen receptorMedicineMedulloblastomaRadiation therapyTumor microenvironmentBrain tumorGliomaImmunotherapyT cellCancer researchBioinformaticsImmunologyTumor cellsInternal medicineBiologyImmune systemPathologyPersistenceTraffickingTargeted TherapyFocused ultrasoundPediatric Brain TumorsCar-t CellsCellular ExhaustionReceptors, Chimeric AntigenBrain NeoplasmsT-LymphocytesRC581-607Immunotherapy, AdoptiveCell MovementHumansAnimalsImmunologic diseases. Allergy